There are benign and malignant lung tumors, how long early lung tumor patients can survive is related to the nature of the tumor, whether the treatment is timely, and whether there is a combination of basic diseases, etc. Benign tumors can live almost as long as ordinary people after active treatment. Benign lung tumors can be treated actively in the early stage and most of them can live almost as long as ordinary people, while malignant lung tumors can be treated correctly in the early stage and usually can live more than 5 years, and most of the patients’ life expectancy is close to that of ordinary people.1. Benign tumors: such as lung malformation, bronchial adenomas, sclerosing hemangiomas and so on, most of the patients can have good recovery after the treatment after the discovery of benign tumors in the early stage and timely treatment such as surgical resection of lesion parts and so on, and most of them do not affect their life expectancy. Most of the patients will recover well after treatment, and most of them will not affect the life span, such as lung malignant tumor, etc. 2. Malignant tumors: the more common malignant lung tumors are lung cancer, lung malignant lymphoma, etc. The earlier the clinical staging, the more the detection, the better the outcome. The earlier the clinical stage, the earlier the discovery and the earlier the treatment, the better the prognosis and the longer the time of life, most of the patients with early discovery and active treatment have a survival period of more than 5 years, and even the life expectancy is not affected. It is suggested that patients should actively cooperate with doctors to take appropriate treatment plan as early as possible, actively control and treat underlying diseases such as high blood pressure and diabetes, maintain a good mood in daily life, such as chatting with others, taking a walk, walking slowly or other leisure and recreational activities, etc., and develop good work and rest habits, get up early, go to bed early, and avoid staying up late, etc., which is beneficial to prolonging the survival time for patients with early-stage lung tumors.